{
  "Q0": "Whole exome sequencing (WES)",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4.1": "Yes",
  "Q4.2": "ACMG",
  "Q5": "Yes",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9.1": "Yes",
  "Q10": "No",
  "Q10.1": "Diagnostic",
  "Q11": "Yes",
  "Q12": "Yes",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14.1": "81415",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "The policy does not specify detailed claim submission steps, but documentation should include the patient's clinical information showing progressive gait instability, muscle stiffness, decreased visual acuity since age 6, inconclusive prior metabolic screening and targeted gene panel, positive family history (paternal aunt with similar neurodegenerative presentation), and that the test was ordered by a Pediatric Neurologist. The appropriate CPT code (81415) should be included.",
  "match": true
}